First Time Loading...

Nova Leap Health Corp
XTSX:NLH

Watchlist Manager
Nova Leap Health Corp Logo
Nova Leap Health Corp
XTSX:NLH
Watchlist
Price: 0.22 CAD -2.22% Market Closed
Updated: Apr 28, 2024
Section:
 

Relative Value

NLH doesn't have a meaningful market cap.

The Relative Value of one NLH stock under the Base Case scenario is 0.34 CAD. Compared to the current market price of 0.22 CAD, Nova Leap Health Corp is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NLH Relative Value
Base Case
0.34 CAD
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
76
vs Industry
78
Median 3Y
0.8
Median 5Y
0.9
Industry
2.4
Forward
0.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-13.2
Industry
23.2
Forward
11.6
More Details
6.4
P/OCF
P/OCF
Price to OCF
6.4
vs History
77
vs Industry
44
Median 3Y
12.8
Median 5Y
13.1
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
35
Median 3Y
-5.2
Median 5Y
6.6
Industry
23.5
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
82
vs Industry
69
Median 3Y
1.1
Median 5Y
1.9
Industry
2.2
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
77
vs Industry
78
Median 3Y
0.8
Median 5Y
1.1
Industry
2.5
Forward
0.3
More Details
1.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.4
vs History
77
vs Industry
76
Median 3Y
2.4
Median 5Y
3.1
Industry
5.2
More Details
10.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.3
vs History
66
vs Industry
33
Median 3Y
10.1
Median 5Y
27.3
Industry
12.5
Forward
5
More Details
30.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30.2
vs History
12
vs Industry
14
Median 3Y
-26.2
Median 5Y
-33.6
Industry
17.2
Forward
0
More Details
6.4
EV/OCF
EV/OCF
Enterprise Value to OCF
6.4
vs History
77
vs Industry
45
Median 3Y
14.3
Median 5Y
14.3
Industry
15.1
More Details
6.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
6.5
vs History
77
vs Industry
39
Median 3Y
14.5
Median 5Y
14.5
Industry
19.7
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
82
vs Industry
68
Median 3Y
1
Median 5Y
1.6
Industry
2
More Details

Multiples Across Competitors

NLH Competitors Multiples
Nova Leap Health Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Nova Leap Health Corp
XTSX:NLH
19m CAD 0.5 -13.2 10.3 30.2
US
Cigna Group
XMUN:CGN
96.6B EUR 0.5 20.1 10.3 13.8
US
Cigna Corp
NYSE:CI
103.7B USD 0.5 20.1 10.3 13.8
US
CVS Health Corp
NYSE:CVS
86.5B USD 0.2 10.4 8.9 8.9
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR 1.1 44.4 10.4 24.6
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD 1.4 38.6 11.8 17.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.3B EUR 0.7 -25.8 9.9 22.2
US
Quest Diagnostics Inc
NYSE:DGX
14.9B USD 1.6 17.7 10.6 14.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 22 6.7 15.9
US
DaVita Inc
NYSE:DVA
11.9B USD 1 17.1 8.4 12.3
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
NLH intrinsic value, competitors valuation, and company profile.
DCF Valuation
NLH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NLH stock valuation using valuation multiples.
Wall Street Estimates
NLH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NLH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.